Latest / Philadelphia News Today | 2 Min News | The Daily News Now!
FDA Approves First Disease-Slowing Alzheimer’s Drug | Philadelphia News
FDA just approved Leqembi, the first Alzheimer’s drug in decades to slow disease progression by targeting brain plaques—offering cautious hope for early-stage patients, though side effects and modest benefits mean careful use and ongoing monitoring. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View sources & latest updates:https://sources.thednn.ai/dfebd072098a7bfb
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.